Tandem launches Clinical Decision Support for clinicians
The CDS tool is embedded in Ask Tandem chat, providing sourced answers to clinical questions during consultations. It is CE marked as Class IIa medical device.
See the latest news and media coverage for Tandem. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI clinical documentation platform
tandemhealth.aiLast updated
In short: Tandem secured $50 million in Series A funding, achieved EU MDR Class IIa certification for its AI scribe, and expanded across European markets.
The CDS tool is embedded in Ask Tandem chat, providing sourced answers to clinical questions during consultations. It is CE marked as Class IIa medical device.
achieving the highest regulatory standard for a clinical AI scribe in Europe
The inspection concluded that AI scribes require Class IIa certification under EU MDR.
It is the first AI scribe in Europe to reach this classification, following independent notified body review.
John F. Sheridan, Tandem's President and CEO, will be leading today's call, and he will be joined by Leigh A. Vosseller, Executive Vice President and...
We provide 13F filing analysis, options flow data, and sector rotation indicators for comprehensive market intelligence. Follow the money and make smarter investment decisions with...
US FDA clears Tandem Diabetes Care's Control-IQ+AID technology for use in pregnancy complicated type 1 diabetes mellitus: San Diego Wednesday, April 29, 2026, 16:00 Hrs...
Doctor Care Anywhere has partnered with Tandem Health to integrate artificial intelligence into its virtual primary care platform.
Track Tandem and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Tandem and other trending companies.